The company is participating in one-to-one meetings with three individual investors as part of investor relations activities.
The meeting is scheduled for October 14, 2026 and will be conducted in physical mode at Mumbai location.
The purpose of the meeting is general investor interaction and engagement.
The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company explicitly states that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
Relevant press releases and investor presentations proposed to be discussed are available on the company's website (www.fermentabiotech.com) and stock exchange portals.
The company notes that changes may occur due to exigencies on the part of the company or investors.
Additional Notes Section
The disclosure represents a standard regulatory intimation of investor meetings without attached financial presentations or detailed agendas.
No financial data, performance figures, or strategic updates were disclosed in this announcement.
The document was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head – Legal (Membership No. A33861) on October 09, 2026, at 11:41:53 IST.
